CS logo
small CS logo
Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie

Frankfurt Am Main, Germany
Hospital in Frankfurt, Hessen
Schleusenweg 2 - 16, 60528 Frankfurt am Main

About Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
German Cancer Research Center
1
National Center for Tumor Diseases, Heidelberg
1
Total Rows: 3

Clinical Trials at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie


During the past decade, Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100001100001100Started TrialsCompleted Trails201520162017201800.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
2012-07-13
2019-09-27
Completed
95
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
2012-06-29
2016-01-21
Completed
135
Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
2015-06-01
2017-09-19
Completed
39
AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma
2018-10-19
2024-09-01
Recruiting
60

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" #1 collaborator was "German Cancer Research Center" with 1 trials as a collaborator, "Neuro-Oncology Working Group of the German Cancer Society" with 1 trials as a collaborator and "University Hospital Heidelberg" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 3Hoffmann-La Roche: 3German CancerResearch Center: 1German CancerResearch Center: 1National Center forTumor Diseases,Heidelberg: 1National Center forTumor Diseases,Heidelberg: 1

Created with Highcharts 11.1.0Top CollaboratorsGerman CancerResearch Center: 1German CancerResearch Center: 1Neuro-OncologyWorking Group of theGerman CancerSociety: 1Neuro-OncologyWorking Group of theGerman CancerSociety: 1University Hospital Heidelberg: 1University Hospital Heidelberg: 1

Clinical Trials Conditions at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie


According to Clinical.Site data, the most researched conditions in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are "Glioblastoma" (1 trials), "Glioma" (1 trials), "Malignant Glioma" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie


Most popular intervention types in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Placebo" (2 trials), "Avelumab" (1 trials), "IDH1 peptide vaccine" (1 trials) and "IDH1R132H peptide vaccine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie


The vast majority of trials in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are 5 trials for "All" genders.

Clinical Trials Status at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie


Currently, there are NaN active trials in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 2Phase 1: 2Phase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Recruiting: 1Recruiting: 1